Recent Finacing
Recent Raise
Adrenergics develops therapeutics for dilated cardiomyopathy non-responders, targeting a common disease driver; operates from COI Pharmaceuticals in San Diego with Avalon-led management, GSK R&D and acquisition option.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors